Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1945 24
1946 43
1947 118
1948 126
1949 95
1950 144
1951 148
1952 148
1953 165
1954 200
1955 251
1956 213
1957 202
1958 216
1959 229
1960 205
1961 213
1962 220
1963 458
1964 670
1965 485
1966 477
1967 543
1968 668
1969 706
1970 785
1971 941
1972 1061
1973 1404
1974 1269
1975 1293
1976 1331
1977 1330
1978 1424
1979 1585
1980 1752
1981 1873
1982 2299
1983 2346
1984 2516
1985 2692
1986 2867
1987 2738
1988 2718
1989 2859
1990 3134
1991 3058
1992 3070
1993 3144
1994 3152
1995 3262
1996 3438
1997 3465
1998 3555
1999 3515
2000 3841
2001 3622
2002 3607
2003 4049
2004 4087
2005 4415
2006 4589
2007 4755
2008 5091
2009 5041
2010 5365
2011 5575
2012 6124
2013 6467
2014 6778
2015 6996
2016 7341
2017 8114
2018 9173
2019 10622
2020 12047
2021 12580
2022 12437
2023 11636
2024 3426

Text availability

Article attribute

Article type

Publication date

Search Results

224,714 results

Results by year

Filters applied: . Clear all
Page 1
Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion.
Webster L, Gudin J, Raffa RB, Kuchera J, Rauck R, Fudin J, Adler J, Mallick-Searle T. Webster L, et al. Pain Med. 2020 Apr 1;21(4):714-723. doi: 10.1093/pm/pnz356. Pain Med. 2020. PMID: 31917418 Free PMC article. Review.
The panel also provided clinical recommendations on the appropriate use of buprenorphine and conversion strategies for switching to buprenorphine from a full -opioid receptor agonist for chronic pain management. ...RESULTS: The panel recommended that …
The panel also provided clinical recommendations on the appropriate use of buprenorphine and conversion strategies for switchi …
Treating Chronic Pain with Buprenorphine-The Practical Guide.
Case AA, Kullgren J, Anwar S, Pedraza S, Davis MP. Case AA, et al. Curr Treat Options Oncol. 2021 Nov 18;22(12):116. doi: 10.1007/s11864-021-00910-8. Curr Treat Options Oncol. 2021. PMID: 34791564 Review.
It may be useful in patients with comorbid substance use disorder or non-medical opioid use, as there is less risk of misuse, euphoria and it may improve mood. When used to treat opioid use disorder, the training and waiver was rec …
It may be useful in patients with comorbid substance use disorder or non-medical opioid use, as there is less ri …
A Neuropharmacological Model to Explain Buprenorphine Induction Challenges.
Greenwald MK, Herring AA, Perrone J, Nelson LS, Azar P. Greenwald MK, et al. Ann Emerg Med. 2022 Dec;80(6):509-524. doi: 10.1016/j.annemergmed.2022.05.032. Epub 2022 Aug 6. Ann Emerg Med. 2022. PMID: 35940992 Review.
Buprenorphine induction for treating opioid use disorder is being implemented in emergency care. ...We present data from clinical studies of buprenorphine induction and propose a neuropharmacologic working model, which posits that acute c
Buprenorphine induction for treating opioid use disorder is being implemented in emergency care. ...We present
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations.
Coe MA, Lofwall MR, Walsh SL. Coe MA, et al. J Addict Med. 2019 Mar/Apr;13(2):93-103. doi: 10.1097/ADM.0000000000000457. J Addict Med. 2019. PMID: 30531584 Free PMC article. Review.
: Buprenorphine is an effective treatment for opioid use disorder. As a high-affinity, partial agonist for the mu-opioid receptor, buprenorphine suppresses opioid withdrawal and craving, reduces illicit opioid use, an …
: Buprenorphine is an effective treatment for opioid use disorder. As a high-affinity, partial agonist for the m …
Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option.
Davis MP, Pasternak G, Behm B. Davis MP, et al. Drugs. 2018 Aug;78(12):1211-1228. doi: 10.1007/s40265-018-0953-z. Drugs. 2018. PMID: 30051169 Free PMC article. Review.
Although originally designed as an analgesic, buprenorphine has mainly been used for opioid maintenance therapy and only now is increasingly recognized as an effective analgesic with an improved therapeutic index relative to certain potent opioids. ...We brie …
Although originally designed as an analgesic, buprenorphine has mainly been used for opioid maintenance therapy and only now i …
Municipal offers and principles for substitution treatment for abuse and addiction to opioids.
Mortensen JB, Andersen CU, Eriksen T, Lund T, Pedersen S, Møller T, Sædder EA. Mortensen JB, et al. Ugeskr Laeger. 2023 May 22;185(21):V09220529. Ugeskr Laeger. 2023. PMID: 37264884 Free article. Review. Danish.
Opioid use disorders can be treated with psychosocial interventions which aim to increase quality of life and minimize problems maintaining drug use. ...The principle for OMT is substituting to another opioid with a more favourable pharmacologic
Opioid use disorders can be treated with psychosocial interventions which aim to increase quality of life and minimize
Buprenorphine in the Treatment of Chronic Pain.
Rudolf GD. Rudolf GD. Phys Med Rehabil Clin N Am. 2020 May;31(2):195-204. doi: 10.1016/j.pmr.2020.02.001. Epub 2020 Mar 13. Phys Med Rehabil Clin N Am. 2020. PMID: 32279723 Review.
Buprenorphine is an opioid that is available for treatment of both chronic pain and opioid use disorder. Its use for chronic pain has been hampered by various factors including complex and often misunderstood pharmacology, challenges to t
Buprenorphine is an opioid that is available for treatment of both chronic pain and opioid use disorder.
Opioids and Opioid Use Disorder in Pregnancy.
Sanjanwala AR, Lim G, Krans EE. Sanjanwala AR, et al. Obstet Gynecol Clin North Am. 2023 Mar;50(1):229-240. doi: 10.1016/j.ogc.2022.10.015. Obstet Gynecol Clin North Am. 2023. PMID: 36822706 Review.
As such, all obstetric providers have a responsibility to provide evidence-based care for patients with opioid use disorder to mitigate adverse outcomes associated with substance use during pregnancy....
As such, all obstetric providers have a responsibility to provide evidence-based care for patients with opioid use disorder
The history and pharmacology of buprenorphine: New advances in cats.
Clark TP. Clark TP. J Vet Pharmacol Ther. 2022 Jul;45 Suppl 1:S1-S30. doi: 10.1111/jvp.13073. J Vet Pharmacol Ther. 2022. PMID: 35790013 Review.
Since then, advances in receptor theory and molecular cloning of opioid receptors have led to a deeper understanding of buprenorphine pharmacology. More recent studies of receptor affinity and intrinsic activity have shown that buprenorphine is a mu- and kapp …
Since then, advances in receptor theory and molecular cloning of opioid receptors have led to a deeper understanding of buprenorph
Clinical Management of Opioid Withdrawal.
Torres-Lockhart KE, Lu TY, Weimer MB, Stein MR, Cunningham CO. Torres-Lockhart KE, et al. Addiction. 2022 Sep;117(9):2540-2550. doi: 10.1111/add.15818. Epub 2022 Feb 22. Addiction. 2022. PMID: 35112746 Review.
Appropriate clinical management of opioid withdrawal is a crucial bridge to long-term treatment for opioid use disorder (OUD), because it is a high-risk time for potential opioid overdose and relapse. ...In addition, we discuss complex cases, re …
Appropriate clinical management of opioid withdrawal is a crucial bridge to long-term treatment for opioid use disor
224,714 results
You have reached the last available page of results. Please see the User Guide for more information.